from Taxus-Stent.com:
The TAXUS™ Express²™ Paclitaxel-Eluting
Coronary Stent System has the power to reduce restenosis, treat a variety
of lesions and achieve safe, predictable outcomes for patients.
- Efficacy - The TAXUS Express² Stent
has demonstrated consistently low revascularization rates throughout
the stent, including its edges and across a broad range of
patient and lesion types.
- Safety - The TAXUS Stent has demonstrated
consistent safety results and endothelial healing across trials
and lesions.
- Performance - The proven Express² Stent
platform exhibits excellent deliverability and conformability,
allowing you to treat a variety of lesions and making it easy
to achieve complete stent apposition.
|
 |
For more detailed information on the Taxus stent,
read our profile of the device.
|
